Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Carole B Pinnock"'
Autor:
Damien A. Leach, Paul A. Drew, David Tamblyn, Tina Kopsaftis, Samarth Chopra, Gail P. Risbridger, Carole B Pinnock, Roxanne Toivanen, Renea A. Taylor, Eric Smith, Grant Buchanan, Donald B. DeFranco, Eleanor F. Need, Jeff Holst, Georgina M. England, Peng Lee, Andrew P. Trotta, Helen M. Palethorpe
Publikováno v:
ResearcherID
Oncotarget
Oncotarget
Androgen receptor (AR) signaling in stromal cells is important in prostate cancer, yet the mechanisms underpinning stromal AR contribution to disease development and progression remain unclear. Using patient-matched benign and malignant prostate samp
Autor:
Stephen Kinsey-Trotman, Scott Walsh, Zumin Shi, Kim Moretti, Tina Kopsaftis, Carole B Pinnock, Martin Borg
Publikováno v:
Radiotherapy and Oncology. 107:129-133
Background and purpose: To assess the association between PSA velocity (PSAV) in the first 24 months after external beam radiotherapy (EBRT) and prostate cancer-specific mortality (PCSM) and all cause mortality. Conclusion: A rapid decline in PSA i
Autor:
Samarth Chopra, David Tamblyn, Tina Kopsaftis, Michael W. Kattan, Changhong Yu, Carole B Pinnock
Publikováno v:
BJU International. 108:51-56
What's known on the subject? and What does the study add? Prognostic tools, such as the Cancer of the Prostate Risk Assessment (CAPRA) score and the 1998 Kattan and 2006 Stephenson nomograms, predicting biochemical recurrence after radical prostatect
Publikováno v:
Health Information & Libraries Journal. 21:94-101
Objectives: A clinical informationist could provide the best available published evidence in response to clinicians’ questions identified during the process of care. This study sought to assess the feasibility of an informationist service and to pr
Autor:
Carole B Pinnock, Jenny Doust, Debra Rowett, Christopher A Silagy, S Nicholson, David Weller, Frank May, Adrian Esterman
Publikováno v:
Family Practice. 20:655-661
Background. Prostate-specific antigen (PSA) testing for prostate cancer is controversial. Demand for PSA testing is likely to rise in the UK, Australia and other western countries. Primary care needs to develop appropriate strategies to respond to th
Publikováno v:
BJU International. 84:799-804
Objective To determine the natural course of patients with subjectively disappointing early results after transurethral prostatectomy (TURP), who experience prolonged discomfort and an initial deterioration in symptoms. Patients and methods A consecu
Publikováno v:
ANZ Journal of Surgery. 71:297-300
Background: The advantages of promoting evidence-based care through implementation of clinical guidelines are well established. Clinical practice guidelines have been developed for lower urinary tract symptoms (LUTS) and prostate cancer screening. As
Publikováno v:
Australasian Journal on Ageing. 19:2-10
Publikováno v:
Urology. 54:834-838
Objectives. To identify predictors of poor symptomatic improvement after transurethral resection of the prostate (TURP), we investigated mucosal cell abnormalities in men about to undergo this procedure, and any association between these abnormalitie
Publikováno v:
Medical Journal of Australia. 169:25-28
OBJECTIVE To determine the prevalence and other characteristics of self-reported blood testing (prostate-specific antigen [PSA]) for prostate cancer in the community. DESIGN Interview-based prevalence study. PARTICIPANTS AND SETTING 695 men aged 40 y